Synergistic Effect of 1,3,6-Trihydroxy-4,5,7-Trichloroxanthone in Combination with Doxorubicin on B-Cell Lymphoma Cells and Its Mechanism of Action Through Molecular Docking

BACKGROUND: The increasing rate of cancer chemoresistance and adverse side effects of therapy have led to the wide use of various chemotherapeutic combinations in cancer management, including lymphoid malignancy. OBJECTIVE: We investigated the effects of a combination of 1,3,6-trihydroxy-4,5,7-trich...

Descripción completa

Detalles Bibliográficos
Autores principales: Miladiyah, Isnatin, Yuanita, Emmy, Nuryadi, Satyo, Jumina, Jumina, Haryana, Sofia Mubarika, Mustofa, Mustofa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037593/
https://www.ncbi.nlm.nih.gov/pubmed/32123546
http://dx.doi.org/10.1016/j.curtheres.2020.100576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037593/
https://www.ncbi.nlm.nih.gov/pubmed/32123546
http://dx.doi.org/10.1016/j.curtheres.2020.100576

Ejemplares similares